Utah Medical Products ROE 2012-2026 | UTMD
Current and historical return on equity (ROE) values for Utah Medical Products (UTMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Utah Medical Products ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-06-30 | $0.01B | $0.12B | 10.02% |
| 2026-03-31 | $0.01B | $0.12B | 10.11% |
| 2025-12-31 | $0.01B | $0.12B | 10.17% |
| 2025-09-30 | $0.01B | $0.12B | 10.21% |
| 2025-06-30 | $0.01B | $0.12B | 10.92% |
| 2025-03-31 | $0.01B | $0.12B | 10.79% |
| 2024-12-31 | $0.01B | $0.12B | 11.36% |
| 2024-09-30 | $0.02B | $0.13B | 11.90% |
| 2024-06-30 | $0.02B | $0.13B | 11.90% |
| 2024-03-31 | $0.02B | $0.13B | 12.75% |
| 2023-12-31 | $0.02B | $0.12B | 13.01% |
| 2023-09-30 | $0.02B | $0.12B | 14.23% |
| 2023-06-30 | $0.02B | $0.12B | 14.72% |
| 2023-03-31 | $0.02B | $0.11B | 15.21% |
| 2022-12-31 | $0.02B | $0.11B | 15.53% |
| 2022-09-30 | $0.02B | $0.11B | 14.85% |
| 2022-06-30 | $0.02B | $0.11B | 14.78% |
| 2022-03-31 | $0.02B | $0.11B | 13.86% |
| 2021-12-31 | $0.01B | $0.11B | 13.05% |
| 2021-09-30 | $0.01B | $0.11B | 12.24% |
| 2021-06-30 | $0.01B | $0.10B | 11.62% |
| 2021-03-31 | $0.01B | $0.10B | 9.98% |
| 2020-12-31 | $0.01B | $0.10B | 10.26% |
| 2020-09-30 | $0.01B | $0.10B | 11.34% |
| 2020-06-30 | $0.01B | $0.10B | 12.47% |
| 2020-03-31 | $0.02B | $0.10B | 15.63% |
| 2019-12-31 | $0.02B | $0.10B | 15.71% |
| 2019-09-30 | $0.01B | $0.09B | 15.14% |
| 2019-06-30 | $0.02B | $0.09B | 18.68% |
| 2019-03-31 | $0.02B | $0.09B | 19.26% |
| 2018-12-31 | $0.02B | $0.09B | 20.93% |
| 2018-09-30 | $0.01B | $0.08B | 14.41% |
| 2018-06-30 | $0.01B | $0.08B | 11.08% |
| 2018-03-31 | $0.01B | $0.08B | 11.29% |
| 2017-12-31 | $0.01B | $0.08B | 11.65% |
| 2017-09-30 | $0.02B | $0.08B | 20.00% |
| 2017-06-30 | $0.01B | $0.07B | 19.18% |
| 2017-03-31 | $0.01B | $0.07B | 18.18% |
| 2016-12-31 | $0.01B | $0.07B | 16.84% |
| 2016-09-30 | $0.01B | $0.07B | 16.78% |
| 2016-06-30 | $0.01B | $0.07B | 17.08% |
| 2016-03-31 | $0.01B | $0.07B | 17.27% |
| 2015-12-31 | $0.01B | $0.07B | 17.78% |
| 2015-09-30 | $0.01B | $0.07B | 18.11% |
| 2015-06-30 | $0.01B | $0.07B | 18.39% |
| 2015-03-31 | $0.01B | $0.07B | 18.60% |
| 2014-12-31 | $0.01B | $0.06B | 18.68% |
| 2014-09-30 | $0.01B | $0.06B | 18.97% |
| 2014-06-30 | $0.01B | $0.06B | 19.51% |
| 2014-03-31 | $0.01B | $0.06B | 20.51% |
| 2013-12-31 | $0.01B | $0.06B | 21.62% |
| 2013-09-30 | $0.01B | $0.05B | 20.75% |
| 2013-06-30 | $0.01B | $0.05B | 21.57% |
| 2013-03-31 | $0.01B | $0.05B | 20.30% |
| 2012-12-31 | $0.01B | $0.05B | 20.94% |
| 2012-09-30 | $0.01B | $0.05B | 22.10% |
| 2012-06-30 | $0.01B | $0.04B | 20.93% |
| 2012-03-31 | $0.01B | $0.04B | 21.69% |
| 2011-12-31 | $0.01B | $0.04B | 17.61% |
| 2011-09-30 | $0.01B | $0.04B | 17.95% |
| 2011-06-30 | $0.01B | $0.04B | 17.95% |
| 2011-03-31 | $0.01B | $0.04B | 15.48% |
| 2010-12-31 | $0.01B | $0.04B | 17.95% |
| 2010-09-30 | $0.01B | $0.04B | 17.95% |
| 2010-06-30 | $0.01B | $0.04B | 18.30% |
| 2010-03-31 | $0.01B | $0.04B | 21.33% |
| 2009-12-31 | $0.01B | $0.04B | 21.92% |
| 2009-09-30 | $0.01B | $0.04B | 22.38% |
| 2009-06-30 | $0.01B | $0.04B | 21.92% |
| 2009-03-31 | $0.01B | $0.04B | 21.33% |
| 2008-12-31 | $0.01B | $0.04B | 20.78% |
| 2008-09-30 | $0.01B | $0.04B | 20.25% |
| 2008-06-30 | $0.01B | $0.04B | 20.51% |
| 2008-03-31 | $0.01B | $0.04B | 20.92% |
| 2007-12-31 | $0.01B | $0.04B | 21.19% |
| 2007-09-30 | $0.01B | $0.04B | 21.62% |
| 2007-06-30 | $0.01B | $0.04B | 22.07% |
| 2007-03-31 | $0.01B | $0.04B | 22.54% |
| 2006-12-31 | $0.01B | $0.04B | 23.02% |
| 2006-09-30 | $0.01B | $0.03B | 23.53% |
| 2006-06-30 | $0.01B | $0.03B | 23.70% |
| 2006-03-31 | $0.01B | $0.03B | 23.70% |
| 2005-12-31 | $0.01B | $0.03B | 23.36% |
| 2005-09-30 | $0.01B | $0.04B | 20.00% |
| 2005-06-30 | $0.01B | $0.04B | 19.31% |
| 2005-03-31 | $0.01B | $0.04B | 18.42% |
| 2004-12-31 | $0.01B | $0.04B | 25.81% |
| 2004-09-30 | $0.02B | $0.04B | 61.54% |
| 2004-06-30 | $0.02B | $0.04B | 69.06% |
| 2004-03-31 | $0.02B | $0.03B | 81.36% |
| 2003-12-31 | $0.02B | $0.02B | 86.60% |
| 2003-09-30 | $0.01B | $0.02B | 42.11% |
| 2003-06-30 | $0.01B | $0.02B | 42.11% |
| 2003-03-31 | $0.01B | $0.02B | 41.03% |
| 2002-12-31 | $0.01B | $0.02B | 40.51% |
| 2002-09-30 | $0.01B | $0.02B | 39.51% |
| 2002-06-30 | $0.01B | $0.02B | 42.11% |
| 2002-03-31 | $0.01B | $0.02B | 40.58% |
| 2001-12-31 | $0.01B | $0.02B | 37.50% |
| 2001-09-30 | $0.01B | $0.02B | 34.48% |
| 2001-06-30 | $0.00B | $0.01B | 30.77% |
| 2001-03-31 | $0.00B | $0.01B | 28.07% |
| 2000-12-31 | $0.00B | $0.02B | 25.40% |
| 2000-09-30 | $0.00B | $0.02B | 22.86% |
| 2000-06-30 | $0.00B | $0.02B | 20.78% |
| 2000-03-31 | $0.00B | $0.02B | 19.51% |
| 1999-12-31 | $0.00B | $0.02B | 18.39% |
| 1999-09-30 | $0.00B | $0.02B | 17.02% |
| 1999-06-30 | $0.00B | $0.03B | 15.69% |
| 1999-03-31 | $0.00B | $0.03B | 15.69% |
| 1998-12-31 | $0.00B | $0.03B | 16.00% |
| 1998-09-30 | $0.00B | $0.02B | 16.49% |
| 1998-06-30 | $0.00B | $0.02B | 17.20% |
| 1998-03-31 | $0.00B | $0.02B | 17.78% |
| 1997-12-31 | $0.00B | $0.02B | 23.88% |
| 1997-09-30 | $0.01B | $0.02B | 29.41% |
| 1997-06-30 | $0.01B | $0.02B | 33.80% |
| 1997-03-31 | $0.01B | $0.01B | 57.14% |
| 1996-12-31 | $0.01B | $0.02B | 40.00% |
| 1996-09-30 | $0.01B | $0.02B | 37.65% |
| 1996-06-30 | $0.01B | $0.02B | 36.36% |
| 1996-03-31 | $0.01B | $0.03B | 28.07% |
| 1995-12-31 | $0.01B | $0.03B | 29.63% |
| 1995-09-30 | $0.01B | $0.03B | 31.37% |
| 1995-06-30 | $0.01B | $0.02B | 33.33% |
| 1995-03-31 | $0.01B | $0.02B | 35.16% |
| 1994-12-31 | $0.01B | $0.02B | 35.16% |
| 1994-09-30 | $0.01B | $0.02B | 34.41% |
| 1994-06-30 | $0.01B | $0.02B | 32.99% |
| 1994-03-31 | $0.01B | $0.03B | 30.77% |
| 1993-12-31 | $0.01B | $0.03B | 30.48% |
| 1993-09-30 | $0.01B | $0.03B | 30.48% |
| 1993-06-30 | $0.01B | $0.03B | 31.37% |
| 1993-03-31 | $0.01B | $0.02B | 33.68% |
| 1992-12-31 | $0.01B | $0.02B | 31.82% |
| 1992-09-30 | $0.01B | $0.02B | 34.57% |
| 1992-06-30 | $0.01B | $0.02B | 37.84% |
| 1992-03-31 | $0.01B | $0.02B | 35.82% |
| 1991-12-31 | $0.01B | $0.02B | 39.34% |
| 1991-09-30 | $0.01B | $0.01B | 37.04% |
| 1991-06-30 | $0.00B | $0.01B | 33.33% |
| 1991-03-31 | $0.00B | $0.01B | 37.21% |
| 1990-12-31 | $0.00B | $0.01B | 42.11% |
| 1990-09-30 | $0.00B | $0.01B | 47.06% |
| 1990-06-30 | $0.00B | $0.01B | 53.33% |
| 1990-03-31 | $0.00B | $0.01B | 57.14% |
| 1989-12-31 | $0.00B | $0.01B | 59.26% |
| 1989-09-30 | $0.00B | $0.01B | 61.54% |
| 1989-06-30 | $0.00B | $0.01B | 46.15% |
| 1989-03-31 | $0.00B | $0.01B | 33.33% |
| 1988-12-31 | $0.00B | $0.01B | 18.18% |
| 1988-09-30 | $0.00B | $0.01B | 0.00% |
| 1988-06-30 | $0.00B | $0.01B | 0.00% |
| 1988-03-31 | $0.00B | $0.00B | 0.00% |
| 1987-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.238B | $0.039B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.551B | 19.40 |
| Medtronic (MDT) | Ireland | $119.919B | 16.39 |
| Stryker (SYK) | United States | $107.976B | 20.18 |
| EssilorLuxottica (ESLOY) | France | $77.566B | 0.00 |
| Boston Scientific (BSX) | United States | $63.578B | 13.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.123B | 0.00 |
| Agilent Technologies (A) | United States | $42.365B | 24.80 |
| Medline (MDLN) | United States | $42.215B | 0.00 |
| ResMed (RMD) | United States | $33.097B | 20.54 |
| GE HealthCare Technologies (GEHC) | United States | $28.940B | 13.84 |
| Koninklijke Philips (PHG) | Netherlands | $24.474B | 13.04 |
| Terumo (TRUMY) | Japan | $21.278B | 20.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.771B | 11.60 |
| Baxter (BAX) | United States | $12.258B | 11.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.762B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.107B | 40.73 |
| Demant (WILYY) | Denmark | $9.694B | 0.00 |
| Insulet (PODD) | United States | $9.657B | 23.72 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.575B | 20.23 |
| Raia Drogasil SA - (RADLY) | $4.998B | 0.00 | |
| BillionToOne (BLLN) | United States | $4.920B | 148.96 |
| Haemonetics (HAE) | United States | $4.832B | 21.20 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $3.972B | 16.82 |
| ICU Medical (ICUI) | United States | $3.896B | 23.27 |
| AtriCure (ATRC) | United States | $2.860B | 244.43 |
| Neogen (NEOG) | United States | $2.672B | 47.12 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.363B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.234B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.214B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.211B | 10.56 |
| Perrigo (PRGO) | Ireland | $1.882B | 5.42 |
| LeMaitre Vascular (LMAT) | United States | $1.835B | 29.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.787B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.780B | 227.44 |
| Kestra Medical Technologies (KMTS) | United States | $1.500B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.445B | 15.42 |
| Phibro Animal Health (PAHC) | United States | $1.422B | 10.91 |
| Omeros (OMER) | United States | $1.243B | 6.29 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.131B | 0.00 |
| CeriBell (CBLL) | United States | $0.961B | 0.00 |
| InMode (INMD) | Israel | $0.855B | 11.90 |
| AdaptHealth (AHCO) | United States | $0.794B | 16.63 |
| VAREX IMAGING (VREX) | United States | $0.778B | 17.10 |
| Glass House Brands (GLAS) | United States | $0.754B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.729B | 7.87 |
| Valneva SE (VALN) | France | $0.622B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.561B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.543B | 0.00 |
| Brainsway (BWAY) | Israel | $0.541B | 30.59 |
| Evolus (EOLS) | United States | $0.522B | 0.00 |
| Cerus (CERS) | United States | $0.504B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.498B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.441B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.413B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.372B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.333B | 24.31 |
| Sanara MedTech (SMTI) | United States | $0.323B | 159.59 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.257B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.248B | 13.17 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| High Tide (HITI) | Canada | $0.226B | 50.80 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.200B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.192B | 0.00 |
| Exagen (XGN) | United States | $0.181B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.156B | 0.00 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| Quanterix (QTRX) | United States | $0.129B | 0.00 |
| Apyx Medical (APYX) | United States | $0.125B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| FitLife Brands (FTLF) | United States | $0.087B | 11.48 |
| ImmuCell (ICCC) | United States | $0.087B | 119.75 |
| Accendra Health (ACH) | United States | $0.085B | 4.83 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.056B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.09 |
| Nephros (NEPH) | United States | $0.047B | 39.00 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.035B | 17.12 |
| United-Guardian (UG) | United States | $0.033B | 13.22 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.020B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |